Market Capitalization (Millions $) |
1,482 |
Shares
Outstanding (Millions) |
46 |
Employees |
850 |
Revenues (TTM) (Millions $) |
398 |
Net Income (TTM) (Millions $) |
-30 |
Cash Flow (TTM) (Millions $) |
26 |
Capital Exp. (TTM) (Millions $) |
42 |
Atricure Inc
Atricure Inc is a leading medical technology company that specializes in the development and commercialization of innovative devices that help surgeons around the world to perform better cardiac surgery procedures. The company's main focus is on the provision of advanced and minimally invasive surgical solutions that enhance patient outcomes and reduce healthcare costs.
Atricure was founded in 2000, and since then, it has become an industry leader in the field of electrophysiology, with a particular focus on the treatment of atrial fibrillation (AF). The company is headquartered in Mason, OH, and has a team of over 900 employees worldwide, including in Europe, Asia, and the Americas.
Atricure's product portfolio includes a range of advanced surgical devices and instruments that are used to treat various cardiac conditions. Some of the company's key products include the AtriCure CryoICE Cryoablation System, the AtriClip Left Atrial Appendage Management System, and the EPi-Sense Coagulation System.
The AtriCure CryoICE Cryoablation System is a minimally invasive system that delivers cold energy to the heart tissue to create a controlled lesion, which stops the abnormal electrical signals that can cause AF. The AtriClip Left Atrial Appendage Management System is designed to exclude the left atrial appendage from the circulation, reducing the risk of stroke in patients with AF.
The EPi-Sense Coagulation System is a bipolar radiofrequency energy device that helps surgeons safely create critically important lines of conduction block in the heart, which can help treat a range of cardiac abnormalities including AF.
Atricure is committed to innovation and product development, maintaining partnerships with leading researchers and medical institutions, and investing significant amounts in R&D every year. The company's culture is rooted in collaboration, integrity, passion, and excellence, and it places a significant emphasis on investing in employee development, diversity, and inclusion.
In conclusion, Atricure Inc is a leading medical technology company that has been at the forefront of innovation in the field of cardiac surgery. With a robust product portfolio, a strong commitment to R&D, and a culture of excellence, the company is well-positioned to achieve sustained growth and remain an industry leader in the years to come.
Company Address: 7555 Innovation Way Mason 45040 OH
Company Phone Number: 755-4100 Stock Exchange / Ticker: NASDAQ ATRC
|